POSTED
February 09, 2025
SHARE VIA
Every year, Rare Disease Day (February 28) and Glanzmann Thrombasthenia Awareness Day (March 1) provide an opportunity to shine a light on conditions that often go unnoticed. With over 300 million people worldwide living with a rare disease, awareness is the first step toward progress—whether it’s in research, treatment, or support for those affected.
One of these rare diseases is Glanzmann Thrombasthenia (GT), an inherited bleeding disorder that prevents blood from clotting properly. Even minor injuries can result in prolonged, uncontrollable bleeding, making everyday life unpredictable and challenging for those affected.
GT is caused by a genetic mutation that affects platelets, the blood cells responsible for clotting. Unlike other bleeding disorders, such as hemophilia, people with GT have a normal platelet count, but their platelets don’t work correctly. This can lead to frequent nosebleeds, heavy menstrual bleeding, and excessive bleeding after surgery or injury. There is currently no cure for GT, and treatment options focus on managing symptoms and preventing excessive blood loss.
Many rare diseases, including GT, go undiagnosed or misunderstood due to a lack of awareness. Without proper knowledge, individuals with GT may face delayed diagnoses, mismanagement of bleeding episodes, or limited access to treatment options.
By spreading awareness, we can:
Raising awareness doesn’t require grand gestures—small actions can significantly impact. Here’s how you can help:
This Rare Disease Day and GT Awareness Day, let’s come together to make rare diseases more visible. Awareness leads to action, and action leads to change. Be a voice for the rare disease community—share, learn, and advocate.